ArticleCancer medicine2024

Neoadjuvant chemoimmunotherapy was associated with better short-term survival of patients with locally advanced esophageal squamous cell carcinoma compared to neoadjuvant chemoradiotherapy.

Xiaofeng Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.